Kel Vin Tan

Qing Liu^*,1,2, 

Kel Vin Tan^*,3, 

Hing-Chiu Chang³, 

Pek-Lan Khong³, 

Xiaoyan Hui^1,2,4 

¹State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, 

²Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 

³Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 

⁴School of Biomedical Sciences, Institute of Vascular Medicine, Chinese University of Hong Kong 

Kel Vin Tan^*,1,2, 

Xinxiang Yang^*,3, 

Chung Ying Chan², 

Jingjing Shi¹, 

Hing-Chiu Chang⁴, 

Keith Wan-Hang Chiu^1,5, 

Kwan Man³ 

¹Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, 

²Department of Oncology, MRC Oxford Institute for Radiation Oncology, University of Oxford, 

³Department of Surgery, School of Clinical Medicine, HKU-SZH & LKS Faculty of Medicine, The University of Hong Kong, 

⁴Department of Biomedical Engineering, The Chinese University of Hong Kong, 

⁵Department of Diagnostic and Interventional Radiology, Kwong Wah Hospital